yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q51782986-52412F82-3FF7-4396-97E4-1E5DCB274CA9
Q51782986-52412F82-3FF7-4396-97E4-1E5DCB274CA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51782986-52412F82-3FF7-4396-97E4-1E5DCB274CA9
Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation.
P2860
Q51782986-52412F82-3FF7-4396-97E4-1E5DCB274CA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51782986-52412F82-3FF7-4396-97E4-1E5DCB274CA9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
79dcb4111eefaf7aecaf3a39a400168031f367e4
P2860
The cardiovascular effects of erythropoietin.